Literature DB >> 6234118

T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function.

U Tjernlund, P Cesaro, E Tournier, J D Degos, J F Bach, M A Bach.   

Abstract

Pokeweed mitogen (PWM)-driven immunoglobulin synthesis (IgG, IgA, IgM) and concanavalin A (Con A)-stimulated suppression of allogeneic mixed leukocyte reaction (MLR) were studied and compared to T-cell subsets defined by monoclonal antibodies OKT4 and OKT8 in patients with multiple sclerosis (MS). The group of patients with active progressive MS showed diminished suppressor activity as measured by T-cell functional tests and also an elevated OKT4/OKT8 ratio. The group of MS patients in remission did not show these abnormalities. However, this correlation between functional tests and T-cell phenotypes was not found when separate individuals were considered within the subgroups of MS. Since neither OKT4 nor OKT8-reactive cells represent homogeneous functional subsets of T cells, the OKT4/OKT8 ratio does not account for the functional immunological status of separate individuals but rather provides a global evaluation of T-cell subset disturbances in different groups of diseases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234118     DOI: 10.1016/0090-1229(84)90120-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  10 in total

1.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

2.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

3.  The clinical use of monoclonal anti-T-cell antibodies.

Authors:  J F Bach; L Chatenoud
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

Review 4.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

6.  Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

Authors:  J C Craig; S A Hawkins; M W Swallow; J A Lyttle; V H Patterson; J D Merrett; M Haire
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

7.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

8.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?

Authors:  A Henneberg; E G Fischer; H H Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

10.  Suppressor and cytolytic cell function in multiple sclerosis. Effects of cyclosporine A and interleukin 2.

Authors:  M B Bania; J P Antel; A T Reder; M K Nicholas; B G Arnason
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.